chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram liver abnormal, Computerised tomogram thorax abnormal, Condition aggravated, Encephalopathy, Endotracheal intubation
Clinical narrative: Patient is a 80 y.o. female with history of Parkinsons disease, severe dementia s/p chronic PEG  admitted to the hospital on 9/3/2023 for encephalopathy, hypoxia. Intubated on arrival. Found to be COVID-19 positive. Concern for staph bacteremia, followed by ID with repeat blood cx NGTD. Extubated 9/06/2023. Discharged to home ECF on 9/11/2023 Acute respiratory failure with hypoxia -Intubated in the setting of hypoxia and altered mentation, COVID-19 may also be contributing -Intubated on admit, extubated 9/6/2023.  -Now on RA, treatment of steroids as outlined below   Severe sepsis -Sources include pulmonary or less likely bacteremia with coag negative staph.  She was previously treated with antibiotics, and infectious disease service followed, now off antibiotics   COVID-19 -Reportedly with symptom onset 8/30/2023. Tested positive at ECF on 9/01 -Previously treated at ECF with paxlovid. Held on admit as not able to crush through PEG -Continue decadron 6mg x10 day total   Abnormal CT scan, chest -Recommend repeat CT scan of the chest in 1 month to reevaluate.   Failure to thrive in adult -Severe baseline dementia and Parkinson's, with PEG for nutritional support. Required intubation during hospitalization  -Overall guarded prognosis.   Acute on chronic encephalopathy -Returned to baseline encephalopathy   Parkinsons disease -Continue home med   Hypertension Orthostatic hypotension -Likely exacerbated by agitation, steroid use -Held home florinef -Follow up on BP in 1 week   Hepatic cysts -Likely incidental finding on CT
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic cyst, Hypotension, Hypoxia, Malaise, Mental status changes
Clinical narrative: Patient is a 80 y.o. female with history of Parkinsons disease, severe dementia s/p chronic PEG  admitted to the hospital on 9/3/2023 for encephalopathy, hypoxia. Intubated on arrival. Found to be COVID-19 positive. Concern for staph bacteremia, followed by ID with repeat blood cx NGTD. Extubated 9/06/2023. Discharged to home ECF on 9/11/2023 Acute respiratory failure with hypoxia -Intubated in the setting of hypoxia and altered mentation, COVID-19 may also be contributing -Intubated on admit, extubated 9/6/2023.  -Now on RA, treatment of steroids as outlined below   Severe sepsis -Sources include pulmonary or less likely bacteremia with coag negative staph.  She was previously treated with antibiotics, and infectious disease service followed, now off antibiotics   COVID-19 -Reportedly with symptom onset 8/30/2023. Tested positive at ECF on 9/01 -Previously treated at ECF with paxlovid. Held on admit as not able to crush through PEG -Continue decadron 6mg x10 day total   Abnormal CT scan, chest -Recommend repeat CT scan of the chest in 1 month to reevaluate.   Failure to thrive in adult -Severe baseline dementia and Parkinson's, with PEG for nutritional support. Required intubation during hospitalization  -Overall guarded prognosis.   Acute on chronic encephalopathy -Returned to baseline encephalopathy   Parkinsons disease -Continue home med   Hypertension Orthostatic hypotension -Likely exacerbated by agitation, steroid use -Held home florinef -Follow up on BP in 1 week   Hepatic cysts -Likely incidental finding on CT
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary sepsis, SARS-CoV-2 test positive, Sepsis, Staphylococcal infection
Clinical narrative: Patient is a 80 y.o. female with history of Parkinsons disease, severe dementia s/p chronic PEG  admitted to the hospital on 9/3/2023 for encephalopathy, hypoxia. Intubated on arrival. Found to be COVID-19 positive. Concern for staph bacteremia, followed by ID with repeat blood cx NGTD. Extubated 9/06/2023. Discharged to home ECF on 9/11/2023 Acute respiratory failure with hypoxia -Intubated in the setting of hypoxia and altered mentation, COVID-19 may also be contributing -Intubated on admit, extubated 9/6/2023.  -Now on RA, treatment of steroids as outlined below   Severe sepsis -Sources include pulmonary or less likely bacteremia with coag negative staph.  She was previously treated with antibiotics, and infectious disease service followed, now off antibiotics   COVID-19 -Reportedly with symptom onset 8/30/2023. Tested positive at ECF on 9/01 -Previously treated at ECF with paxlovid. Held on admit as not able to crush through PEG -Continue decadron 6mg x10 day total   Abnormal CT scan, chest -Recommend repeat CT scan of the chest in 1 month to reevaluate.   Failure to thrive in adult -Severe baseline dementia and Parkinson's, with PEG for nutritional support. Required intubation during hospitalization  -Overall guarded prognosis.   Acute on chronic encephalopathy -Returned to baseline encephalopathy   Parkinsons disease -Continue home med   Hypertension Orthostatic hypotension -Likely exacerbated by agitation, steroid use -Held home florinef -Follow up on BP in 1 week   Hepatic cysts -Likely incidental finding on CT
Age: 82.0
Sex: F
Vaccine: FLUA4
Symptoms: Asthenia, Dizziness, Mobility decreased
Clinical narrative: PATIENT FELT WEAK IN THE EVENING,   COULD NOT GET OUT OF CHAIR.  DIZZINESS.  WENT TO ER AND WAS OBSERVED AND RELEASED
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Irritability, Nausea, Pain, Somnolence
Clinical narrative: Pain in the area, sleepy. Irritation. Nausea.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient is a 77 y.o. male patient with history of DM, HTN, prostate ca, HLD presented to Hospital with weakness, who was found to have COVID-19.    Covid 19 virus infection Main symptom weakness, occasional dry cough Vitals stable, Currently on room air  CRP 31 CXR Persistent mild left basilar opacity may be due to scarring.  Mild atelectasis and/or a small left pleural effusion could also be present. Pneumonia is not suspected. PT/OT evaluated recommending home therapy, will also need tub seat prior to discharge  Social work consulted for assistance, however patient declining home health Being discharged with paxlovid, has four more doses left  Instructed to not take statin while on paxlovid  Tessalon as needed for cough    Hypertension Toprol dosing decreased from 200 to 100 mg daily while in the hospital  Will send in new prescription    Diabetes mellitus type 2 HgbA1c 7.1 Home metformin being held  Accu-Cheks with coverage Diabetic diet   HLD On rosuvastatin at home, currently on hold due being on paxlovid
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Glycosylated haemoglobin increased, Lung opacity, Pleural effusion, Pulmonary fibrosis
Clinical narrative: Patient is a 77 y.o. male patient with history of DM, HTN, prostate ca, HLD presented to Hospital with weakness, who was found to have COVID-19.    Covid 19 virus infection Main symptom weakness, occasional dry cough Vitals stable, Currently on room air  CRP 31 CXR Persistent mild left basilar opacity may be due to scarring.  Mild atelectasis and/or a small left pleural effusion could also be present. Pneumonia is not suspected. PT/OT evaluated recommending home therapy, will also need tub seat prior to discharge  Social work consulted for assistance, however patient declining home health Being discharged with paxlovid, has four more doses left  Instructed to not take statin while on paxlovid  Tessalon as needed for cough    Hypertension Toprol dosing decreased from 200 to 100 mg daily while in the hospital  Will send in new prescription    Diabetes mellitus type 2 HgbA1c 7.1 Home metformin being held  Accu-Cheks with coverage Diabetic diet   HLD On rosuvastatin at home, currently on hold due being on paxlovid
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Therapy change
Clinical narrative: Patient is a 77 y.o. male patient with history of DM, HTN, prostate ca, HLD presented to Hospital with weakness, who was found to have COVID-19.    Covid 19 virus infection Main symptom weakness, occasional dry cough Vitals stable, Currently on room air  CRP 31 CXR Persistent mild left basilar opacity may be due to scarring.  Mild atelectasis and/or a small left pleural effusion could also be present. Pneumonia is not suspected. PT/OT evaluated recommending home therapy, will also need tub seat prior to discharge  Social work consulted for assistance, however patient declining home health Being discharged with paxlovid, has four more doses left  Instructed to not take statin while on paxlovid  Tessalon as needed for cough    Hypertension Toprol dosing decreased from 200 to 100 mg daily while in the hospital  Will send in new prescription    Diabetes mellitus type 2 HgbA1c 7.1 Home metformin being held  Accu-Cheks with coverage Diabetic diet   HLD On rosuvastatin at home, currently on hold due being on paxlovid
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Blood test normal, Crying, Headache, Hyporesponsive to stimuli, Pallor
Clinical narrative: Patient was fine in the clinic and waited 15 minutes before leaving clinic after she received the injection.  Caregiver called the clinic at 10:19 AM and stated her daughter was having a severe Headache.  She stated she was crying stating her head hurt so bad.  Caregiver gave child 3 ibuprofen and then was going to take the child to the MD office and she stated that her daughter the patient turned white and was very slow to respond.  She went to the ER and said upon admission her B/P was 124/46.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Urine analysis normal
Clinical narrative: Patient was fine in the clinic and waited 15 minutes before leaving clinic after she received the injection.  Caregiver called the clinic at 10:19 AM and stated her daughter was having a severe Headache.  She stated she was crying stating her head hurt so bad.  Caregiver gave child 3 ibuprofen and then was going to take the child to the MD office and she stated that her daughter the patient turned white and was very slow to respond.  She went to the ER and said upon admission her B/P was 124/46.
Age: 68.0
Sex: M
Vaccine: YF
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccination was administered. After administration, reporter noticed that patient had received MMR vaccine at different location on 9/25/23. This is within the recommended window of >4 weeks separation of live vaccines. Per CDC recommendations, this dose of yellow fever would not count as a dose and would need to be readministered.
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Cough, Dysphonia, Flushing, Rash, Throat tightness
Clinical narrative: Hoarsness, tightness in throat, coughing, rash on arms, flushing in face (occured twelve minutes after dose 0.3 epi 1mg/1cc-  taken to ER
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: We received the childrens vaccine on 10/6/2023 when I was not at work.  I was not aware that we received the childrens vaccine.  In an effort to do the most efficient thing for our store due to being behind on all the rx ques I thought using the single dose vials would be most efficient when the most staff was one hand to use them up.  It was discovered when using the NDC for another patient that this was the children's dose due to the rx adjudicating. the patient returned and received the adult dosage according the CDC recommendations.
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Anaemia, Angiogram, Angiogram pulmonary normal, Anticoagulant therapy
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Back pain, Bacterial test positive, Bacteriuria, Blood culture positive
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: CHA2DS2-VASc-score, COVID-19, Chest pain, Condition aggravated, Cough
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Culture urine positive, Dysuria, Escherichia test positive, Flank pain, Glycosylated haemoglobin
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Haemoglobin decreased, Hypoxia, Oropharyngeal pain, Platelet count decreased, Pyrexia
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Streptococcus test positive, Urine analysis abnormal
Clinical narrative: Patient is a 93 y.o. female with a history of a fib, T1DM, CML, chronic thrombocytopenia who presented to ED 9/8/2023 for chest and back pain with cough and fevers. In ED, she was found to be in a fib with RVR, COVID 19 positive and with bacteruria. CTA TAP nonacute. She was transferred to Facility 9/8/2023 for ongoing management.   1. Atrial fibrillation with RVR: known history of A fib. CHADS2Vasc 5. Follows with Dr. (cardio). S/p cardizem drip on admit. Improved on arrival to Facility. BB and eliquis continued.  2. COVID-19 Infection: presented with sore throat, fevers, cough on 9/7/23. Vaccinated. Positive test 9/8/23. CTPA nonacute on admit. Started on decadron on admit due to hypoxia, continued on discharge; pt requested paxlovid. Isolation per protocol. 3. Acute Respiratory Failure with Hypoxia: in setting of COVID. Required 2LPM per NC in ED. CTPA on admit nonacute; no PE. Weaned off O2 9/9/23.  4. Bacteruria: with increased frequency and mild dysuria as well as occasional right flank pain PTA. UA with bacteria on admit; Cx 9/8/23 grew >10K EColi. 1 of 2 blood cx 9/8/23 grew strep mitis; suspect contaminant. IV Rocephin completed 9/10/23.  5. T1DM: per history. Follows with Dr. (endo). A1c 6.1 on 8/30/23. Continued home dose of Lantus on admit, dose reduced her carb coverage on admit as she reported not being exact at home.  6. CML: per history, follows with Dr. (heme/onc). Previously on hydroxyurea, stopped in 7/2023 due to minimal improvement in labs. Continued outpatient follow up  7. Chronic Thrombocytopenia: in setting of CML. Plt on admit 44, baseline around 50-80.  8. Anemia: in setting of CML. Hbg on admit at baseline at 10.7.  9. Code status: full code, confirmed on admit 10. DVT Prophylaxis: Eliquis
Age: 23.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Burning sensation
Clinical narrative: burning sensation in right arm going up to the right scapula that started this morning
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angina unstable, Angiogram cerebral abnormal, Angiogram pulmonary abnormal, Anticoagulant therapy
Clinical narrative: Patient is a 76 y.o. male with a history of T2DM, CAD, OSA, CVA, recent admit to hospital 8/19/23 for unstable angina who presented to facility 9/3/2023 with complaints of generalized weakness and falls. COVID 19 positive. CTA head/neck and CTPA showed incidental acute PE with RV strain, with prox Lt ICA stenosis. Transferred to facility on 9/3/23 for further management of acute PE.   1. Acute Submassive PE: likely provoked secondary to COVID-19. initially seen on CTA head/neck. Confirmed on CTPA involving Rt main PA with mild RV strain. Negative troponin, slightly elevated BNP. Venous doppler with acute LLE DVT, limited echo with EF59% and stable RV. S/p Heparin gtt, transitioned to lovenox bid per PV recs. Not a candidate for DOAC due to medication interaction, will need coumadin or lovenox on dc for 3-6 months.    2. COVID 19 infection: vaccinated x 2. Symptoms starting 9/2/23. Tested positive 9/3/23. Treated with IV dexamethasone (stop 9/14) and remdesivir (stop 9/8).  3. Acute hypoxic respiratory failure: likely due to PE, possibly COVID-19. Mild diffuse peripheral ground glass changes on CTPA. Unable to wean to RA on 9/4/2023 .Continue supplemental O2 for goal SpO2 > 90%.    4. CAD with angina: h/o with multiple stents. NM stress test 8/30/23 abnormal with mild/moderate reversible lesion. ECHO 8/19/23 showed EF 60% with grade 1 DD. Troponin negative on admit. Discussed with interventional cardio (Dr.) 9/5/23, rec likely okay to continue plavix and anticoagulation as to avoid triple therapy and plan for outpatient LHC since pt without chest pain and negative trops. 5. Carotid artery stenosis: admit CTA showed 70 prox Lt ICA stenosis. Continued AP and statin. Recommend OP follow up.  6. Falls: likely due to weakness, COVID and PE. No acute injury on trauma imaging. Denies LOC but did hit head. No fractures on admit imaging. Trauma evaluated. PT/OT eval.  7. HTN: h/o. Contiued home BB and held ACEI. Resume as able.    8. T2DM: h/o. Last HbA1c 6.8. held home PO medications. ISS for now.  9. CVA: per history. Continued aspirin, plavix, statin, consider AP adjustment given new need for AC as above  10. Trigeminal neuralgia: h/o. Continued home tegretol and gabapentin.  11. Obesity: BMI 34.46. recommend lifestyle modifications  12. OSA: per chart but noncompliant with CPAP. Rec outpatient sleep evaluation
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram carotid abnormal, Asthenia, Brain natriuretic peptide increased, COVID-19, Cardiac stress test abnormal
Clinical narrative: Patient is a 76 y.o. male with a history of T2DM, CAD, OSA, CVA, recent admit to hospital 8/19/23 for unstable angina who presented to facility 9/3/2023 with complaints of generalized weakness and falls. COVID 19 positive. CTA head/neck and CTPA showed incidental acute PE with RV strain, with prox Lt ICA stenosis. Transferred to facility on 9/3/23 for further management of acute PE.   1. Acute Submassive PE: likely provoked secondary to COVID-19. initially seen on CTA head/neck. Confirmed on CTPA involving Rt main PA with mild RV strain. Negative troponin, slightly elevated BNP. Venous doppler with acute LLE DVT, limited echo with EF59% and stable RV. S/p Heparin gtt, transitioned to lovenox bid per PV recs. Not a candidate for DOAC due to medication interaction, will need coumadin or lovenox on dc for 3-6 months.    2. COVID 19 infection: vaccinated x 2. Symptoms starting 9/2/23. Tested positive 9/3/23. Treated with IV dexamethasone (stop 9/14) and remdesivir (stop 9/8).  3. Acute hypoxic respiratory failure: likely due to PE, possibly COVID-19. Mild diffuse peripheral ground glass changes on CTPA. Unable to wean to RA on 9/4/2023 .Continue supplemental O2 for goal SpO2 > 90%.    4. CAD with angina: h/o with multiple stents. NM stress test 8/30/23 abnormal with mild/moderate reversible lesion. ECHO 8/19/23 showed EF 60% with grade 1 DD. Troponin negative on admit. Discussed with interventional cardio (Dr.) 9/5/23, rec likely okay to continue plavix and anticoagulation as to avoid triple therapy and plan for outpatient LHC since pt without chest pain and negative trops. 5. Carotid artery stenosis: admit CTA showed 70 prox Lt ICA stenosis. Continued AP and statin. Recommend OP follow up.  6. Falls: likely due to weakness, COVID and PE. No acute injury on trauma imaging. Denies LOC but did hit head. No fractures on admit imaging. Trauma evaluated. PT/OT eval.  7. HTN: h/o. Contiued home BB and held ACEI. Resume as able.    8. T2DM: h/o. Last HbA1c 6.8. held home PO medications. ISS for now.  9. CVA: per history. Continued aspirin, plavix, statin, consider AP adjustment given new need for AC as above  10. Trigeminal neuralgia: h/o. Continued home tegretol and gabapentin.  11. Obesity: BMI 34.46. recommend lifestyle modifications  12. OSA: per chart but noncompliant with CPAP. Rec outpatient sleep evaluation
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Carotid artery stenosis, Deep vein thrombosis, Diastolic dysfunction, Echocardiogram abnormal, Ejection fraction normal
Clinical narrative: Patient is a 76 y.o. male with a history of T2DM, CAD, OSA, CVA, recent admit to hospital 8/19/23 for unstable angina who presented to facility 9/3/2023 with complaints of generalized weakness and falls. COVID 19 positive. CTA head/neck and CTPA showed incidental acute PE with RV strain, with prox Lt ICA stenosis. Transferred to facility on 9/3/23 for further management of acute PE.   1. Acute Submassive PE: likely provoked secondary to COVID-19. initially seen on CTA head/neck. Confirmed on CTPA involving Rt main PA with mild RV strain. Negative troponin, slightly elevated BNP. Venous doppler with acute LLE DVT, limited echo with EF59% and stable RV. S/p Heparin gtt, transitioned to lovenox bid per PV recs. Not a candidate for DOAC due to medication interaction, will need coumadin or lovenox on dc for 3-6 months.    2. COVID 19 infection: vaccinated x 2. Symptoms starting 9/2/23. Tested positive 9/3/23. Treated with IV dexamethasone (stop 9/14) and remdesivir (stop 9/8).  3. Acute hypoxic respiratory failure: likely due to PE, possibly COVID-19. Mild diffuse peripheral ground glass changes on CTPA. Unable to wean to RA on 9/4/2023 .Continue supplemental O2 for goal SpO2 > 90%.    4. CAD with angina: h/o with multiple stents. NM stress test 8/30/23 abnormal with mild/moderate reversible lesion. ECHO 8/19/23 showed EF 60% with grade 1 DD. Troponin negative on admit. Discussed with interventional cardio (Dr.) 9/5/23, rec likely okay to continue plavix and anticoagulation as to avoid triple therapy and plan for outpatient LHC since pt without chest pain and negative trops. 5. Carotid artery stenosis: admit CTA showed 70 prox Lt ICA stenosis. Continued AP and statin. Recommend OP follow up.  6. Falls: likely due to weakness, COVID and PE. No acute injury on trauma imaging. Denies LOC but did hit head. No fractures on admit imaging. Trauma evaluated. PT/OT eval.  7. HTN: h/o. Contiued home BB and held ACEI. Resume as able.    8. T2DM: h/o. Last HbA1c 6.8. held home PO medications. ISS for now.  9. CVA: per history. Continued aspirin, plavix, statin, consider AP adjustment given new need for AC as above  10. Trigeminal neuralgia: h/o. Continued home tegretol and gabapentin.  11. Obesity: BMI 34.46. recommend lifestyle modifications  12. OSA: per chart but noncompliant with CPAP. Rec outpatient sleep evaluation
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram ST-T segment abnormal, Fall, Head injury, Lung opacity, Pulmonary embolism
Clinical narrative: Patient is a 76 y.o. male with a history of T2DM, CAD, OSA, CVA, recent admit to hospital 8/19/23 for unstable angina who presented to facility 9/3/2023 with complaints of generalized weakness and falls. COVID 19 positive. CTA head/neck and CTPA showed incidental acute PE with RV strain, with prox Lt ICA stenosis. Transferred to facility on 9/3/23 for further management of acute PE.   1. Acute Submassive PE: likely provoked secondary to COVID-19. initially seen on CTA head/neck. Confirmed on CTPA involving Rt main PA with mild RV strain. Negative troponin, slightly elevated BNP. Venous doppler with acute LLE DVT, limited echo with EF59% and stable RV. S/p Heparin gtt, transitioned to lovenox bid per PV recs. Not a candidate for DOAC due to medication interaction, will need coumadin or lovenox on dc for 3-6 months.    2. COVID 19 infection: vaccinated x 2. Symptoms starting 9/2/23. Tested positive 9/3/23. Treated with IV dexamethasone (stop 9/14) and remdesivir (stop 9/8).  3. Acute hypoxic respiratory failure: likely due to PE, possibly COVID-19. Mild diffuse peripheral ground glass changes on CTPA. Unable to wean to RA on 9/4/2023 .Continue supplemental O2 for goal SpO2 > 90%.    4. CAD with angina: h/o with multiple stents. NM stress test 8/30/23 abnormal with mild/moderate reversible lesion. ECHO 8/19/23 showed EF 60% with grade 1 DD. Troponin negative on admit. Discussed with interventional cardio (Dr.) 9/5/23, rec likely okay to continue plavix and anticoagulation as to avoid triple therapy and plan for outpatient LHC since pt without chest pain and negative trops. 5. Carotid artery stenosis: admit CTA showed 70 prox Lt ICA stenosis. Continued AP and statin. Recommend OP follow up.  6. Falls: likely due to weakness, COVID and PE. No acute injury on trauma imaging. Denies LOC but did hit head. No fractures on admit imaging. Trauma evaluated. PT/OT eval.  7. HTN: h/o. Contiued home BB and held ACEI. Resume as able.    8. T2DM: h/o. Last HbA1c 6.8. held home PO medications. ISS for now.  9. CVA: per history. Continued aspirin, plavix, statin, consider AP adjustment given new need for AC as above  10. Trigeminal neuralgia: h/o. Continued home tegretol and gabapentin.  11. Obesity: BMI 34.46. recommend lifestyle modifications  12. OSA: per chart but noncompliant with CPAP. Rec outpatient sleep evaluation
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin normal, Ultrasound Doppler abnormal, Weaning failure
Clinical narrative: Patient is a 76 y.o. male with a history of T2DM, CAD, OSA, CVA, recent admit to hospital 8/19/23 for unstable angina who presented to facility 9/3/2023 with complaints of generalized weakness and falls. COVID 19 positive. CTA head/neck and CTPA showed incidental acute PE with RV strain, with prox Lt ICA stenosis. Transferred to facility on 9/3/23 for further management of acute PE.   1. Acute Submassive PE: likely provoked secondary to COVID-19. initially seen on CTA head/neck. Confirmed on CTPA involving Rt main PA with mild RV strain. Negative troponin, slightly elevated BNP. Venous doppler with acute LLE DVT, limited echo with EF59% and stable RV. S/p Heparin gtt, transitioned to lovenox bid per PV recs. Not a candidate for DOAC due to medication interaction, will need coumadin or lovenox on dc for 3-6 months.    2. COVID 19 infection: vaccinated x 2. Symptoms starting 9/2/23. Tested positive 9/3/23. Treated with IV dexamethasone (stop 9/14) and remdesivir (stop 9/8).  3. Acute hypoxic respiratory failure: likely due to PE, possibly COVID-19. Mild diffuse peripheral ground glass changes on CTPA. Unable to wean to RA on 9/4/2023 .Continue supplemental O2 for goal SpO2 > 90%.    4. CAD with angina: h/o with multiple stents. NM stress test 8/30/23 abnormal with mild/moderate reversible lesion. ECHO 8/19/23 showed EF 60% with grade 1 DD. Troponin negative on admit. Discussed with interventional cardio (Dr.) 9/5/23, rec likely okay to continue plavix and anticoagulation as to avoid triple therapy and plan for outpatient LHC since pt without chest pain and negative trops. 5. Carotid artery stenosis: admit CTA showed 70 prox Lt ICA stenosis. Continued AP and statin. Recommend OP follow up.  6. Falls: likely due to weakness, COVID and PE. No acute injury on trauma imaging. Denies LOC but did hit head. No fractures on admit imaging. Trauma evaluated. PT/OT eval.  7. HTN: h/o. Contiued home BB and held ACEI. Resume as able.    8. T2DM: h/o. Last HbA1c 6.8. held home PO medications. ISS for now.  9. CVA: per history. Continued aspirin, plavix, statin, consider AP adjustment given new need for AC as above  10. Trigeminal neuralgia: h/o. Continued home tegretol and gabapentin.  11. Obesity: BMI 34.46. recommend lifestyle modifications  12. OSA: per chart but noncompliant with CPAP. Rec outpatient sleep evaluation
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, FLU4, PNC13, RV5
Symptoms: Chest X-ray normal, Culture urine negative, Influenza virus test negative, Perioral dermatitis, Pyrexia
Clinical narrative: pt started with rash around mouth  then with spread to trunk and back with fever of 101 given motrin  taken to ER and temp 104 rectally - given tylenol and monitored
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, FLU4, PNC13, RV5
Symptoms: Rash, SARS-CoV-2 test negative, Urine analysis normal
Clinical narrative: pt started with rash around mouth  then with spread to trunk and back with fever of 101 given motrin  taken to ER and temp 104 rectally - given tylenol and monitored
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Rash, Rash pruritic
Clinical narrative: Chills (acetaminophen taken) Itchy rash on entire back, chest, abdomen and upper arms (antihistamine taken)
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Atelectasis, Atrial fibrillation, Bradycardia
Clinical narrative: Patient is a 80 y.o. female patient of CNP with history of COPD A-fib CAD  presented to Hospital with shortness of breath now admitted for COPD exacerbation due to COVID infection.   Acute on chronic hypoxic respiratory failure Secondary to COVID infection Pneumonia due to COVID and pseudomonas Covid-19 Virus Infection Date of onset of symptoms: 8/26 Symptoms present on admission: SOB Date of covid positive test: 8/28 Vaccination status: vaccinated x 1, no booster Imaging: CXR with increased density in left lung, atelectasis vs infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 9/5 Wears 2L at home came in initially needing BiPAP Chest x-ray with possible infiltrate Completed steroids  Breathing treatments Sputum cx grew pseudomonas-change antibiotic from ceftriaxone to cefepime on 9/2 Wean oxygen to home dose of 2-3L Positive D-dimer, CTPA neg for PE Much improved   Bradycardia Started on 8/31 - going into 40's and occ 30s Remdesivir started on 8/31 - can cause bradycardia Hold parameters on metoprolol S/p remdesivir, now stopped  Improved - maintained in the 50's or above Elevated troponin Likely demand ischemia from Afib and COVID infection Admission EKG-Afib RVR Troponin downtrending Denies any chest pain   A-fib RVR -now rate controlled Not on AC due to bleeding with Eliquis in the past Continue home metoprolol and diltiazem   Anemia- iron deficiency Baseline hb 12, admission hb 10.2 Hb 7.7 today -8/29/23 (?Dilutional) Cnt Home ferrous sulfate Transfuse if hb <7 Hemoglobin is stable.  Outpatient evaluation and management.   Hypertension, uncontrolled Home Cozaar Added amlodipine 9/1 Metoprolol already on board but occ held due to bradycardia   CAD Plavix, metoprolol, lipitor   Malnutrition BMI 17 Dietician consult
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient is a 80 y.o. female patient of CNP with history of COPD A-fib CAD  presented to Hospital with shortness of breath now admitted for COPD exacerbation due to COVID infection.   Acute on chronic hypoxic respiratory failure Secondary to COVID infection Pneumonia due to COVID and pseudomonas Covid-19 Virus Infection Date of onset of symptoms: 8/26 Symptoms present on admission: SOB Date of covid positive test: 8/28 Vaccination status: vaccinated x 1, no booster Imaging: CXR with increased density in left lung, atelectasis vs infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 9/5 Wears 2L at home came in initially needing BiPAP Chest x-ray with possible infiltrate Completed steroids  Breathing treatments Sputum cx grew pseudomonas-change antibiotic from ceftriaxone to cefepime on 9/2 Wean oxygen to home dose of 2-3L Positive D-dimer, CTPA neg for PE Much improved   Bradycardia Started on 8/31 - going into 40's and occ 30s Remdesivir started on 8/31 - can cause bradycardia Hold parameters on metoprolol S/p remdesivir, now stopped  Improved - maintained in the 50's or above Elevated troponin Likely demand ischemia from Afib and COVID infection Admission EKG-Afib RVR Troponin downtrending Denies any chest pain   A-fib RVR -now rate controlled Not on AC due to bleeding with Eliquis in the past Continue home metoprolol and diltiazem   Anemia- iron deficiency Baseline hb 12, admission hb 10.2 Hb 7.7 today -8/29/23 (?Dilutional) Cnt Home ferrous sulfate Transfuse if hb <7 Hemoglobin is stable.  Outpatient evaluation and management.   Hypertension, uncontrolled Home Cozaar Added amlodipine 9/1 Metoprolol already on board but occ held due to bradycardia   CAD Plavix, metoprolol, lipitor   Malnutrition BMI 17 Dietician consult
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram abnormal, Fibrin D dimer increased, Haemoglobin, Lung disorder
Clinical narrative: Patient is a 80 y.o. female patient of CNP with history of COPD A-fib CAD  presented to Hospital with shortness of breath now admitted for COPD exacerbation due to COVID infection.   Acute on chronic hypoxic respiratory failure Secondary to COVID infection Pneumonia due to COVID and pseudomonas Covid-19 Virus Infection Date of onset of symptoms: 8/26 Symptoms present on admission: SOB Date of covid positive test: 8/28 Vaccination status: vaccinated x 1, no booster Imaging: CXR with increased density in left lung, atelectasis vs infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 9/5 Wears 2L at home came in initially needing BiPAP Chest x-ray with possible infiltrate Completed steroids  Breathing treatments Sputum cx grew pseudomonas-change antibiotic from ceftriaxone to cefepime on 9/2 Wean oxygen to home dose of 2-3L Positive D-dimer, CTPA neg for PE Much improved   Bradycardia Started on 8/31 - going into 40's and occ 30s Remdesivir started on 8/31 - can cause bradycardia Hold parameters on metoprolol S/p remdesivir, now stopped  Improved - maintained in the 50's or above Elevated troponin Likely demand ischemia from Afib and COVID infection Admission EKG-Afib RVR Troponin downtrending Denies any chest pain   A-fib RVR -now rate controlled Not on AC due to bleeding with Eliquis in the past Continue home metoprolol and diltiazem   Anemia- iron deficiency Baseline hb 12, admission hb 10.2 Hb 7.7 today -8/29/23 (?Dilutional) Cnt Home ferrous sulfate Transfuse if hb <7 Hemoglobin is stable.  Outpatient evaluation and management.   Hypertension, uncontrolled Home Cozaar Added amlodipine 9/1 Metoprolol already on board but occ held due to bradycardia   CAD Plavix, metoprolol, lipitor   Malnutrition BMI 17 Dietician consult
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Myocardial ischaemia, Pneumonia pseudomonal, Positive airway pressure therapy, Pseudomonas test positive
Clinical narrative: Patient is a 80 y.o. female patient of CNP with history of COPD A-fib CAD  presented to Hospital with shortness of breath now admitted for COPD exacerbation due to COVID infection.   Acute on chronic hypoxic respiratory failure Secondary to COVID infection Pneumonia due to COVID and pseudomonas Covid-19 Virus Infection Date of onset of symptoms: 8/26 Symptoms present on admission: SOB Date of covid positive test: 8/28 Vaccination status: vaccinated x 1, no booster Imaging: CXR with increased density in left lung, atelectasis vs infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 9/5 Wears 2L at home came in initially needing BiPAP Chest x-ray with possible infiltrate Completed steroids  Breathing treatments Sputum cx grew pseudomonas-change antibiotic from ceftriaxone to cefepime on 9/2 Wean oxygen to home dose of 2-3L Positive D-dimer, CTPA neg for PE Much improved   Bradycardia Started on 8/31 - going into 40's and occ 30s Remdesivir started on 8/31 - can cause bradycardia Hold parameters on metoprolol S/p remdesivir, now stopped  Improved - maintained in the 50's or above Elevated troponin Likely demand ischemia from Afib and COVID infection Admission EKG-Afib RVR Troponin downtrending Denies any chest pain   A-fib RVR -now rate controlled Not on AC due to bleeding with Eliquis in the past Continue home metoprolol and diltiazem   Anemia- iron deficiency Baseline hb 12, admission hb 10.2 Hb 7.7 today -8/29/23 (?Dilutional) Cnt Home ferrous sulfate Transfuse if hb <7 Hemoglobin is stable.  Outpatient evaluation and management.   Hypertension, uncontrolled Home Cozaar Added amlodipine 9/1 Metoprolol already on board but occ held due to bradycardia   CAD Plavix, metoprolol, lipitor   Malnutrition BMI 17 Dietician consult
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Sputum culture positive, Troponin increased
Clinical narrative: Patient is a 80 y.o. female patient of CNP with history of COPD A-fib CAD  presented to Hospital with shortness of breath now admitted for COPD exacerbation due to COVID infection.   Acute on chronic hypoxic respiratory failure Secondary to COVID infection Pneumonia due to COVID and pseudomonas Covid-19 Virus Infection Date of onset of symptoms: 8/26 Symptoms present on admission: SOB Date of covid positive test: 8/28 Vaccination status: vaccinated x 1, no booster Imaging: CXR with increased density in left lung, atelectasis vs infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 9/5 Wears 2L at home came in initially needing BiPAP Chest x-ray with possible infiltrate Completed steroids  Breathing treatments Sputum cx grew pseudomonas-change antibiotic from ceftriaxone to cefepime on 9/2 Wean oxygen to home dose of 2-3L Positive D-dimer, CTPA neg for PE Much improved   Bradycardia Started on 8/31 - going into 40's and occ 30s Remdesivir started on 8/31 - can cause bradycardia Hold parameters on metoprolol S/p remdesivir, now stopped  Improved - maintained in the 50's or above Elevated troponin Likely demand ischemia from Afib and COVID infection Admission EKG-Afib RVR Troponin downtrending Denies any chest pain   A-fib RVR -now rate controlled Not on AC due to bleeding with Eliquis in the past Continue home metoprolol and diltiazem   Anemia- iron deficiency Baseline hb 12, admission hb 10.2 Hb 7.7 today -8/29/23 (?Dilutional) Cnt Home ferrous sulfate Transfuse if hb <7 Hemoglobin is stable.  Outpatient evaluation and management.   Hypertension, uncontrolled Home Cozaar Added amlodipine 9/1 Metoprolol already on board but occ held due to bradycardia   CAD Plavix, metoprolol, lipitor   Malnutrition BMI 17 Dietician consult
Age: 60.0
Sex: F
Vaccine: RSV
Symptoms: Erythema, Nodule, Skin warm
Clinical narrative: Approximately 3 inch diameter red, warm to touch, knot that now itches. Taking ibuprofen every 6-10 hours.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 64 YEAR OLD FEMALE PATIENT GIVEN FLUZONE HD
Age: 61.0
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENT IS 61 AND GOT ADMINISTERED FLUAD HIGH DOSE WHICH IS ELEIGIBLE FOR PATIENTS 65 YARS AND OLDER, DUE TO MISCOMMUNICATION ABOUT AGE IN FLU TENT BEFORE BILING INSURANCE